Can a chatbot help end HIV? new study tests digital tool in black MSM
NCT ID NCT05968755
First seen Jan 30, 2026 · Last updated Jun 22, 2026 · Updated 24 times
Summary
This study will test a chatbot designed to increase awareness and use of PrEP, a daily pill that prevents HIV, among Black men who have sex with men (MSM) in the Southern United States. About 145 participants will interact with the chatbot over 90 days, answering questions and receiving personalized PrEP information. The goal is to see if the chatbot can help more men learn about and start taking PrEP, potentially reducing HIV rates in this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREP UPTAKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Care 4 U Community Health Center
Miami, Florida, 33127, United States
-
Community Care Resources of FL (CCRSFL)
Pembroke Pines, Florida, 33027, United States
-
NAESM, Inc
Atlanta, Georgia, 30318, United States
-
RAO Community Health
Charlotte, North Carolina, 28202, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
chatbot
What this could lead to
If successful, this chatbot could become a low-cost tool to increase PrEP use and reduce HIV rates in a high-risk community.
What could go wrong
This is a small, early-stage trial with no control group, so results may not be generalizable. The chatbot's impact on actual HIV prevention is uncertain.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.